Antibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN2841770 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Kinase insert Domain Receptor (A Type III Receptor tyrosine Kinase) (KDR) (AA 1326-1356), (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
- Reactivity
- Human
- Host
- Rabbit
- Epitope
- AA 1326-1356, C-Term
- Antibody clone number
- RB01536
- Vial size
- 80 μL
- Storage
- Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Submitted references Heterotrimeric G alpha q/G alpha 11 proteins function upstream of vascular endothelial growth factor (VEGF) receptor-2 (KDR) phosphorylation in vascular permeability factor/VEGF signaling.
p38 MAPK inhibition is critically involved in VEGFR-2-mediated endothelial cell survival.
Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha ) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1).
A set of loop-1 and -3 structures in the novel vascular endothelial growth factor (VEGF) family member, VEGF-ENZ-7, is essential for the activation of VEGFR-2 signaling.
Zeng H, Zhao D, Yang S, Datta K, Mukhopadhyay D
The Journal of biological chemistry 2003 Jun 6;278(23):20738-45
The Journal of biological chemistry 2003 Jun 6;278(23):20738-45
p38 MAPK inhibition is critically involved in VEGFR-2-mediated endothelial cell survival.
Yilmaz A, Kliche S, Mayr-Beyrle U, Fellbrich G, Waltenberger J
Biochemical and biophysical research communications 2003 Jul 4;306(3):730-6
Biochemical and biophysical research communications 2003 Jul 4;306(3):730-6
Cooperative interaction of hypoxia-inducible factor-2alpha (HIF-2alpha ) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1).
Elvert G, Kappel A, Heidenreich R, Englmeier U, Lanz S, Acker T, Rauter M, Plate K, Sieweke M, Breier G, Flamme I
The Journal of biological chemistry 2003 Feb 28;278(9):7520-30
The Journal of biological chemistry 2003 Feb 28;278(9):7520-30
A set of loop-1 and -3 structures in the novel vascular endothelial growth factor (VEGF) family member, VEGF-ENZ-7, is essential for the activation of VEGFR-2 signaling.
Kiba A, Yabana N, Shibuya M
The Journal of biological chemistry 2003 Apr 11;278(15):13453-61
The Journal of biological chemistry 2003 Apr 11;278(15):13453-61
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- IHC